Contribution of cytochrome P450 4A isoforms to renal functional response to inhibition of nitric oxide production in the rat

Journal of Physiology

Volumn 551, Issue 3, 2003, Pages 971-979

  Hercule, Hantz C ^b   Wang, Mong Heng ^a   Oyekan, Adebayo O ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ANTISENSE OLIGONUCLEOTIDE; CYTOCHROME P450 4A; ICOSANOID; ISOENZYME; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SODIUM; CYTOCHROME P450 4A1; CYTOCHROME P450 4A2; CYTOCHROME P450 4A3; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FATTY ACID SYNTHESIS; FEMALE; GLOMERULUS FILTRATION RATE; HEMODYNAMIC PARAMETERS; INHIBITION KINETICS; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; KIDNEY MICROSOME; KIDNEY TUBULE; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NEPHRON; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SODIUM EXCRETION; ANIMAL CELL; ANIMAL EXPERIMENT; KIDNEY TUBULE FUNCTION; SYNTHESIS;

ALKANE 1-MONOOXYGENASE; ANIMALS; BLOOD PRESSURE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION;

EID: 0141535335     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2003.049981     Document Type: Article

References (34)

1. Alonso-Galicia M, Drummond HA, Reddy KK, Falck JR & Roman RJ (1997). Inhibition of 20-HETE contributes to the vascular responses to nitric oxide. Hypertension 29, 320-325.
2. Carroll MA, Sala A, Dunn CE, McGiff JC & Murphy RC (1991). Structural identification of cytochrome P450-dependent arachidonate metabolites formed by rabbit medullary thick ascending limb cells. J Biol Chem 266, 12306-12312.
3. Escalante B, Erlij D, Falck JR & McGiff JC (1994). Cytochrome P450-arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb. Am J Physiol 266, C1775-1782.
4. Escalante BE, McGiff JC & Oyekan AO (2002). Role of cytochrome P450 arachidonate metabolites in endothelin signaling in the rat proximal tubule. Am J Physiol Renal Physiol 282, F144-150.
5. Gabbai FB, Thomson SC, Peterson O, Wead L, Malvey K & Blantz RC (1995). Glomerular and tubular interactions between renal adrenergic activity and nitric oxide. Am J Physiol 268, F1004-1008.
6. Garcia NH, Stoos BA, Carretero OA & Garvin JL (1996). Mechanism of the nitric oxide-induced blockade of collecting duct water permeability. Hypertension 27, 679-683.
7. Gruetter CA, Ryan ET, Lemke SM, Bailly DA, Fox MK & Schoepp DD (1988). Endothelium-dependent modulation of angiotensin II-induced contraction in blood vessels. Eur J Pharmacol 146, 85-95.
8. Hardwick JP (1991). CYP4A subfamily, functional analysis by immunohistochemistry and in situ hybridization. Methods Enzymol 206, 273-283.
9. Imig JD, Zou A-P, Stec DE, Harder DR, Falck JR & Roman RJ (1996). Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol 270, R217-227.
10. Ito O, Alonso-Galicia M, Hopp KA & Roman RJ (1998). Localization of cytochrome P450 4A isoforms along the rat nephron. Am J Physiol 274, F395-404.
11. Johnson RA & Freeman RH (1992). Pressure natriuresis in rats during blockade of the L-arginine/nitric oxide pathway. Hypertension 19, 333-338.
12. Kimura S, Hanioka N, Matsunaga E & Gonzalez FJ (1989a). The rat clofibrate-inducible CYP4A gene subfamily I. Complete intron and exon sequence of the CYP4A1 and CYP4A2 genes, unique exon organization, and identification of a conserved 19-bp upstream element. DNA 8, 503-516.
13. Kimura S, Hardwick JP, Kozak CA & Gonzalez FJ (1989b). The rat clofibrate-inducible CYP4A gene subfamily. II. cDNA sequence of IVA3, mapping of the Cyp4a locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes. DNA 8, 517-525.
14. McGiff JC & Quilley J (1999). 20-HETE and the kidney, resolution of old problems and new beginnings. Am J Physiol 277, R607-623.
15. Mattson DL & Wu F (2000). Nitirc oxide synthases activity and isoforms in rat renal vasculature. Hypertension 35, 337-341.
16. Mehl M, Daiber A, Herold S, Shoun H & Ullrich V (1999). Peroxynitrite reaction with heme proteins. Nitric Oxide 3, 142-152.
17. Minamiyama Y, Takemura S, Imaoka S, Funae Y, Tanimoto Y & Inoue M (1997). Irreversible inhibition of cytochrome P450 by nitric oxide. J Pharmacol Exp Ther 283, 1479-1485.
18. Omata K, Abraham NG & Schwartzman ML (1992a). Age-related changes in renal cytochrome arachidonic acid metabolism in spontaneously hypertensive rats. Am J Physiol 262, F8-16.
19. Omata K, Abraham NG & Schwartzman ML (1992b). Arachidonic acid ω/ω-1 hydroxylase along the nephron of the spontaneously hypertensive rat. Am J Physiol 262, F592-599.
20. Ortiz PA & Garvin JL (2002). Nitric oxide in the regulation of nephron transport. Am J Physiol Renal Physiol 282, F777-784.
21. Oyekan AO & McGiff JC (1998). Functional response of the rat kidney to inhibition of nitric oxide synthesis, Role of cytochrome P450-derived arachidonate metabolites. Br J Pharmacol 125, 1065-1073.
22. Oyekan AO, Youseff T, Fulton D, Quilley J & McGiff JC (1999). Renal cytochrome P450 Ω-hydroxylase and epoxygenase activity is differentially modified by nitric oxide and NaCl. J Clin Invest 104, 1131-1137.
23. Richard V, Hogie M, Clozel M, Loffler BM & Thuillez C (1995). In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation 91, 771-775.
24. Stromstedt M, Hayashi S, Zaphiropoulos PG & Gustafsson JA (1990). Cloning and characterization of a novel member of the cytochrome P450 subfamily IVA in rat prostate. DNA 9, 567-577.
25. Sundseth SS & Waxman DJ (1993). Sex-dependent expression and clofibrate-inducibility of cytochrome P450 4A fatty acid ω-hydroxylase. J Biol Chem 267, 3915-3921.
26. Vallon V, Peterson OW, Gabbai FB, Blantz RC & Thomson SC (1995). Interactive control of renal function by alpha 2-adrenergic system and nitric oxide, role of angiotensin II. J Cardiovasc Pharmacol 26, 916-922.
27. Wang MH, Guan H, Nguyen X, Zand BA, Nasjletti A & Laniado-Schwartzman M (1999). Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys. Am J Physiol 276, F246-253.
28. Wang MH, Wang J, Chang HH, Nasjletti A & Laniado-Schwartzman M (2002). Regulation of CYP4A1- and CYP4A3-mediated 20-HETE synthesis by nitric oxide. Hypertension 40, 402 (abstract P48).
29. Wang MH, Zhang F, Marji J, Zand BA, Nasiletti A & Laniado-Schwartzman M (2001). CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR. Am J Physiol 280, R255-261.
30. Wilcox CS & Welch WJ (1996). TGF and nitric oxide: effects of salt intake and salt-sensitive hypertension. Kidney Int Suppl 55, S9-13.
31. Wu F, Park F, Cowley AW Jr & Mattson DL (1999). Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney. Am J Physiol 276, F874-881.
32. Zou AP, Imig JD, Kaldunski M, Ortiz de Montellano PR, Sui Z-H & Roman RJ (1994a). Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am J Physiol 266, F275-282.
33. Zou AP, Imig JD, Ortiz De Montellano PR, Sui Z-H, Falck JR & Roman RJ (1994b). Effect of P-450 ω-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am J Physiol 266, F934-941.
34. Ziyyat A, Zhang BL & Benzoni D (1996). Interactions between nitric oxide and prostanoids in isolated perfused kidneys of the rat. Br J Pharmacol 119, 388-392.